Growth, Development, and Stages of Life Flashcards
Well-Check Schedule
Prenatal visit Newborn visit First week visit (3 to 5 days) 1, 2, 3, 4, 6, 9, 12, 15, 18 month visit 2, 2 1/2, 3 year visit Annual visits from 4 to 18 years.
Recommended Childhood and Adolescent Immunizations
- Birth: HepB
- 1m: HepB
- 2m: Polio (IPV), DTaP (diphtheria, tetanus, pertussis); Influenza B (Hib); Pneumococcal (PCV), Rotavirus (RV)
- 4m: DTaP, Hib, IPV, PCV, RV
- 6m: Dtap, Hib, HeptB, IPV, PCV, RV
- 12-15m: Hib, PCV, MMR (measles, mumps, rubella), HepA, varicella.
- 15-18m: DTaP
- 18-33m: HepA
- 4-6y: DTaP, IPV, MMR, varicela.
- 11-12y: MMR (if not yet), Tdap, Meningo (MCV4) with booster at 16y. HPV (2 doses follow at 2 and 6m after first dose)
Hepatitis B Vaccine (HepB)
- Intramuscular
- Birth, 1-2m, 6-18m.
- Contraind: Severe allergic reactions to previous dose or vaccine component (aluminum hydroxide, yeast protein).
- Precautions: infant less than 2kg or moderate to severe acute illness with or without fever.
- HBsAg positive mothers: infant should receive HepB and immunoglobulin (HBIG) within 12 hours of birth. Also, infants should be tested for HBsAg and antibody after completion of HepB series (9 to 18m).
- Mothers whose HBsAg status is unknown: infant should receive the first dose of HepB within 12 hours of birth. Maternal blood should be drawn ASAP, if positive, infant should receive HBIG (no later than a week).
Rotavirus Vaccine (RV)
- Is a cause of of serious gastroenteritis and is nosocomial. Most severe in children 3-24m. (younger than 3 has maternal antibodies).
- Oral route (must replicate in infant’s gut)
- Rotarix: 2 doses (2 and 4m).
- RotaTeq: 3 doses (2, 4 and 6m).
- Do not start the series on or after age 15 weeks.
- The maximum age for the final dose is 8 months.
- Vaccine may be withheld if infant is experiencing severe vomiting and diarrhea. Adm on recovery.
Diphtheria, tetanus, acellular pertussis* (DTaP)
*coqueluche
- Intramuscular
- 5 doses (2, 4, 6, 15-18m, 4-6y).
- DTaP <7y. Should not be adm 5th dose if 4th was given with 4y or later.
- Tdap >7y (adolescent preparation) is recommended at 11 to 12y for children who have completed the DTaP series but have not received a Td booster; children 13-18y who have not received Tdap should receive a dose.
- Td is used as a booster every 10 years after Tdap is adm at 11-18y.
- Encephalopathy is a complication.
- Contraind: encephalopathy within 7 days of a previous dose or severe allergic reaction to a previous dose or component.
Haemophilus Influenzae type B (Hib)
- Protects against numerous serious infections caused by H. influenzae type B, such as bacterial meningitis, epiglottitis, bacterial pneumonia, septic arthritis, and sepsis.
- Intramuscular
- ActHIB, Hiberix, or Pentacel: 4-dose series at 2, 4, 6, 12–15 months
- PedvaxHIB: 3-dose series at 2, 4, 12–15 months.
- Contraind: Severe allergic reaction to previous dose or component.
- Special recommendations to: HIV, chemotherapy or radiation, stem cell transplant, sickle cell disease, splenectomy, immunoglobulin deficience.
Influenza Vaccine
- Recommended annually for children beginning at age 6y. (2 types: LAIV and IIV)
- LAIV should not be used in persons with the following conditions or situations:
- History of severe allergic reaction to a previous dose of any influenza vaccine or to any vaccine component (excluding egg, see details above)
- Receiving aspirin or salicylate-containing medications
- Age 2–4 years with history of asthma or wheezing
- Immunocompromised due to any cause (including medications and HIV infection)
- Anatomic or functional asplenia
- Cochlear implant
- Cerebrospinal fluid-oropharyngeal communication
- Close contacts or caregivers of severely immunosuppressed persons who require a protected environment
- Pregnancy
- Received influenza antiviral medications within the previous 48 hours
Inactivated Poliovirus Vaccine (IPV)
- Subcutaneous (may be given IM)
- 4-dose series at ages 2, 4, 6–18 months, 4–6 years; administer the final dose at or after age 4 years and at least 6 months after the previous dose.
- Contraind: Severe allergic reaction to previous dose or component (formalin, neomycin, streptomycin,or polymyxin)
Measles, Mumps, Rubella (MMR) vaccine
* Sarampo, caxumba e rubeola
- Subcutaneous
- 2-dose series at 12–15 months, 4–6 years. Dose 2 may be administered as early as 4 weeks after dose 1.
- The maximum age for use of MMRV is 12 years.
- Contraind: Severe allergic reaction to previous dose or component (gelatin, neomycin, eggs, pregnancy, known immunodeficiency.
- If child received immunoglobulin, the MMR should be postponed for at least 3-6m.
Varicella Vaccine
- Subcutaneous
- 2-dose series at 12–15 months, 4–6 years. Dose 2 may be administered as early as 3 months after dose 1.
- Children receiving vaccine should avoid aspirin products because of the risk of Reye’s syndrome.
- Contraind: Severe allergic reaction to previous dose or component (gelatin, bovine albumin, neomycin), significant suppression of cellular immunity, pregnancy.
Pneumococcal Conjugate Vaccine (PCV)
- Prevents infection with Streptococcus pneumoniae, which may cause meningitis, pneumonia, septicemia, sinusitis, and otitis media.
- Intramuscular
- 4-dose series at 2, 4, 6, 12–15 months.
- Contraind: Severe allergic reaction to previous dose or component.
Hepatitis A vaccine (HepA)
- Intramuscular
- 2-dose series (minimum interval: 6 months) beginning at age 12 months.
- Contraind: Severe allergic reaction to previous dose or component.
Meningococcal vaccine (MCV)
- MCV4 is the preferred type and is IM.
- 2-dose series at 11–12 years, 16 years.
- adolescents at high school entry (15y) and all college freshmen living in dormitories should be vaccinated.
- Contraindicated in children with history of Guillain-Barre syndrome.
Human papillomavirus vaccine (HPV)
- Guards against type 6, 11, 16, 18 (depending on type).
- most effective before exposure through sexual contact.
- 3 injections over 6 months. Routinely recommended at age 11–12 years (can start at age 9 years).
- second dose 2m after first, and third dose 6m after first dose.
- Vaccine may cause pain, swelling, itching, and redness at the injection site, fever, nausea and dizziness.
- Contraind: pregnant women and reaction to previous vaccine.
Reactions to vaccine
Local reactions:
- Tenderness, erythema, swelling.
- Low-grade fever.
- Behavioral changes, such as drowsiness, unusual crying, decreased appetite.
Minimizing local reactions:
- using appropriate needle and recommended site.
Anaphylactic reaction:
- Protect airway, restore adequate circulation, prevent further exposure.
- Mild reaction: SC injection of antihistamine.
- Moderate to severe: CPR, elevate head, adm epinephrine, fluids and vasopressors as prescribed. Monitor vital signs and urine output.
Development Characteristics: Infant
- Physical
- Height increases 1 inch per month in the first 6 months, and by 1 year the length has increased 50%.
- Weight is doubled at 5 to 6 months and tripled at 12m
- At birth head circ. is 33-35 cm, aprox 2-3 cm more than chest circ.
- Anterior fontanel is soft and flat, closes by 18m.
- Posterior fontanel is soft and flat, closes by 4m.
- First primary teeth to erupt are the lower central incisors at aprox. 6-10m.
Development Characteristics: Infant
- Vital Signs
Newborn:
- 36 to 37.2 C (96.8 to 99.0 F)
- 120-160 bpm
- 30-60 rpm
- BP 80-90/40-50 mmHg
1 year old infant:
- 36.1 to 37.2 C (97 to 99 F)
- 90-130 bpm
- 20-40 rpm
- BP 90/56 mmHg
Development Characteristics: Infant
- Skills
2 to 3 months
- smiles, turns head side to side, follows objects, holds head in midline.
4 to 5 months
- grasps objects, switches objects from hands, rolls over for the first time, enjoys social interaction, begins to show memory, aware of unfamiliar surroundings.
6 to 7 months
- creeps, sits with support, imitates, exhibits fear of strangers, holds arms out, frequent mood swings, waves bye bye.
8 to 9 months
- sits steadily unsupported, crawls, may stand while holding on, begins to stand without help.
10 to 11 months
- can change from prone to sitting, walks while holding to furniture, stands securely, entertains self for periods of time.
12 to 13 months
- walks with 1 hand held, can take a few steps without falling, can drink from a cup.
14 to 15 months
- walks alone, can crawl up stairs, show emotions such as anger and affection, will explore away from mother in familiar surroundings.
Development Characteristics: Toddler
- Physical
- Height and weight increases in phases.
- Head circ. increases about 1 in (25.5 cm) between ages 1 and 2, thereafter increases 12.5 cm (1/2 in) per year until age 5.
- Weight gain is slower, by 2y, the average is 22-27 pounds (10-12kg).
- Normal height changes include about 3in (7.5cm) per year. Average height is 34in (86cm) ate age 2.
- Lordosis (pot belly) is noted.
- Dental care is essential, should never be allowed to fall asleep with bottle (unless with water).
Development Characteristics: Toddler
- Vital Signs
- 36.4 to 37 C (97.5 to 98.6 F)
- 80-120 bpm
- 20-30 rpm
- BP 92/55 mmHg
Development Characteristics: Toddler
- Skills
- Runs by age 2 and walks backward.
- Hops on one feet by age 3.
- begins to master fine motor skills.
- begins to use short sentences and vocabulary has about 300 words by age 2.
Development Characteristics: Preschooler
- Physical
- Grows 2.5 to 3 in per year (6.5 to 7.5).
- Average height is 37 in (94cm) at age 3, 40.5in (103cm) at age 4, and 43in (110cm) at age 5.
- Gains approx. 5 pounds (2.25kg) per year. Averange is 18ks (40 pounds) at age 5.
- Requires about 12 hours of sleep per day.
Development Characteristics: Preschooler
- Vital Signs
- 36.4 to 37 C (97.5 to 98.6 F)
- 70-110 bpm
- 16-22 rpm
- BP 95/57 mmHg
Development Characteristics: Preschooler
- Skills
- has good posture
- develops fine motor coordination
- can hop, skip, and run smoothly
- athletic abilities begin to develop
- increased skill in balancing
- alternates feet when climbing stairs
- can tie shoelaces by age 6
- talk continuously and ask many why question. Vocabulary of about 900 words by age 3 and 2100 by age 5.
- By age 3 talk in 3-4 word sentences. By age 4 speak in 5-6 word sentences and by age 5 speaks in longer sentences .
- child can be understood and can understand clearly what others say.
- By age 5, achieves bowel and bladder control, although accidents may occur.
Development Characteristics: School-age child
- Physical
- Girls usually grow faster.
- growth is about 2in (5cm) per year between ages 6-12
- height ranges from 45in (115cm) ate age 6 to 59in (150cm) ate age 12.
- gain weight at a range of about 4.5-6.5 pounds (2-3kg) per year.
- Average weight is 46 pounds (21kg) at age 6 and 88 pounds (40kg) at age 12.
- The first permanent teeth erupt around age 6.
- sleep requirements range from 10-12 hours.
Development Characteristics: School-age child
- Vital signs
- 36.4 to 37 C (97.5 to 98.6 F)
- 60-100 bpm
- 18-20 rpm
- BP 107/64 mmHg
Development Characteristics: School-age child
- Skills
- refinement of fine motor skills
- development of gross motor skills
- strength and endurance increase
Development Characteristics: Adolescent
- Physical
- Puberty is the maturational, hormonal, and growth process that occurs.
- Body mass increases in adult size
- Sebaceous and sweat glands become active
- body hair distribution occurs
- increases in height, weight, breast development, and pelvic girth occur in girls.
- Menstrual periods occur 2.5 years after onset of puberty.
- in boys, increases in height, weight, muscle mass, and penis and testicle size occur. Voice deepens.
Development Characteristics: Adolescent
- Vital Signs
- 36.4 to 37 C (97.5 - 98.6 F)
- 55-90 bpm
- 12-20 rpm
- BP 121/70 mmHg
Development Characteristics: Early adulthood (late teens to mid 30s)
- Completed physical growth by the age 20.
- Tends to ignore symptoms and postpone seeking health care.
- separates from family origin
- gives much attention to occupation.
Development Characteristics: Middle adulthood (mid 30 to mid 60)
- Physical changes occur between 40 to 65y.
- Menopause occurs in women and climacteric occurs in men.
Near-death physiological manifestations
- Metabolism is reduced, body gradually slows down until all functions end.
- Sensory: experiences blurred vision, decrease sense of taste and smell, decreased pain and touch perception, and loss of blink reflex and appears to stare ( hearing is believed to be the last sense lost).
- Respirations: Rapid or slow, shallow and irregular. May be noisy and wet sounding (death rattle).
- Circulation: HR slows and BP falls progressively. Skin is cool to the touch, and extremities become pale, mottled, and cyanotic. Skin is wax-like very near death.
- Urinary output decreases, incontinence may occur.
- GI motility and peristalsis diminish, leading to constipation, gas accumulation and distension.
- Gradually loses ability to move, has difficulty speaking and swallowing, and loses the gag reflex.
General postmortem procedures
- close eyes
- replace dentures
- wash the body and change bed linens if needed
- place pads under the perineum
- remove tubes and dressings
- straighten the body and place a pillow under the head in preparation for a family viewing